Study to Assess the Burden of Mild Outcomes (Physician Office Visits) Due to Influenza in the United States
NCT02019732 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1
Last updated 2017-01-10
Summary
This is a database study to quantify the burden of multiple mild outcomes (i.e., those that result in visits to a physician's office) attributable to influenza in the United States, stratified by age group, geographic region and influenza subtype for selected influenza seasons.
Conditions
Interventions
- OTHER
-
Data collection
Data collection from existing electronic healthcare databases (Marketscan Commercial database, MarketScan Medicare Supplemental database).
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-01-31
- Primary Completion
- 2013-06-30
- Completion
- 2013-06-30
Countries
- United States
Study Locations
More Related Trials
-
Cost of Illness Associated With Influenza in the UK
NCT01521416 ·Status: COMPLETED
-
B-cell Immunity to Influenza (SLVP017)- Year 1, 2009
NCT02133781 ·Status: COMPLETED ·Phase: PHASE4
-
Respiratory Virus Outpatient Study (FLU 002 Plus)
NCT01056354 ·Status: COMPLETED
-
Does Seasonal Influenza Vaccination Affect the Incidence of pH1N1 Influenza?
NCT01001325 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Influenza-Specific Immune Responses in Children and Adults During the 2010-2011 Influenza Season in the U.S.
NCT01262079 ·Status: COMPLETED
-
Evaluating Modes of Influenza Transmission Observational Study of Community Acquired Influenza
NCT01769430 ·Status: COMPLETED
-
A Prospective Study to Evaluate the Safety of a New Monovalent Intranasal Influenza Vaccine
NCT00873912 ·Status: COMPLETED ·Phase: PHASE4
-
Prophylactic Efficacy of Relenza Against Influenza A and B
NCT01156701 ·Status: COMPLETED
-
Respiratory Virus Hospitalization Study (FLU 003 Plus)
NCT01056185 ·Status: COMPLETED
-
Influenza Vaccination Among the Elderly Individuals
NCT02362919 ·Status: COMPLETED
-
Influenza in People With Normal and Weakened Immune Systems
NCT00533182 ·Status: COMPLETED
-
Safety, Tolerability, Efficacy and Immunogenicity of an Influenza A Vaccine (FP-01.1) in Healthy Volunteers Following Virus Challenge
NCT02071329 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Factors Associated With Maintenance of Antibody Responses to Influenza Vaccine in Older, Community-Dwelling Adults
NCT02401893 ·Status: COMPLETED
-
Safety and Immunogenicity of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine
NCT05027932 ·Status: COMPLETED ·Phase: PHASE1
-
A Systematic Review of Studies of the Effect of Influenza Vaccine Against Mismatched Strains
NCT01416597 ·Status: COMPLETED
-
A Study to Describe Pediatric Influenza Vaccine Coverage
NCT00639418 ·Status: COMPLETED
-
A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza
NCT05160636 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluating Modes of Influenza Transmission 2b Baseline SAR
NCT07342556 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Trial to Assess the Shedding,Immunogenicity, and Safety of FluMist Administered to Healthy Individuals 5-49 Years of Age
NCT00192140 ·Status: COMPLETED ·Phase: PHASE4
-
A Prospective Study to Evaluate the Safety of a New Trivalent Intranasal Influenza Vaccine
NCT00677820 ·Status: COMPLETED ·Phase: PHASE4
-
B-cell Immunity to Influenza (SLVP017)- Year 5, 2013
NCT03020537 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine for the Elderly
NCT00938392 ·Status: COMPLETED ·Phase: PHASE3
-
Revealing Protective Immunity to Influenza Using Systems Immunology
NCT06501963 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Human Immune Responses to Influenza Virus Vaccination in Healthy Volunteers
NCT02385123 ·Status: TERMINATED ·Phase: PHASE4
-
Influenza Antiviral DAS181-F03
NCT01173224 ·Status: COMPLETED ·Phase: PHASE1